No Data
No Data
Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $18
Buy Rating for Mesoblast Driven by Promising Market Opportunities and Upcoming PDUFA Date for Ryoncil
Express News | Mesoblast Ltd : Maxim Group Raises Target Price to $18 From $12
Mesoblast Posts Cash Balance of Over $51 Million in Fiscal Q1
Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $11
Press Release: Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024